Treatment-resistant depression, how TMS therapy actually works, how to verify your insurance, what to expect during your first session. Written for patients and families.
How TMS coil targeting for depression evolved from the 1995 "5cm rule" to functional-connectivity-guided placement over the left dorsolateral prefrontal cortex — what the imaging evidence shows, and why precise targeting matters for response.
What the 2023 Pigott reanalysis of the STAR*D trial found — a cumulative remission rate near 35% rather than the originally published 67% after four sequential antidepressant strategies — and why that revision moves TMS earlier in the treatment pathway.
Why intermittent theta-burst stimulation (iTBS) and standard 10 Hz rTMS produce equivalent response and remission rates in major depression — the THREE-D non-inferiority trial, a decade of supporting evidence, and why iTBS runs about a third as long per session.
Insurance verification takes about two minutes. We'll tell you whether your plan covers TMS for treatment-resistant depression and what your cost will be — before you book anything.
Monday–Friday, 9:00 AM – 5:00 PM